ETAO International Co., Ltd. (ETAO)
NASDAQ: ETAO · IEX Real-Time Price · USD
2.955
+0.165 (5.91%)
At close: Apr 25, 2024, 3:59 PM
2.990
+0.035 (1.18%)
After-hours: Apr 25, 2024, 7:41 PM EDT
ETAO International Co. Market Cap
ETAO International Co. has a market cap or net worth of $15.14 million as of April 25, 2024. Its market cap has decreased by -81.08% in one year.
Market Cap
15.14M
Enterprise Value
13.87M
1-Year Change
-81.08%
Ranking
Category
Stock Price
$2.96
Market Cap Chart
Since May 18, 2021, ETAO International Co.'s market cap has decreased from $65.20M to $15.14M, a decrease of -76.78%. That is a compound annual growth rate of -39.18%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 14.90M | -3.25% |
Apr 23, 2024 | 15.40M | -3.14% |
Apr 22, 2024 | 15.90M | -5.92% |
Apr 19, 2024 | 16.90M | -15.50% |
Apr 18, 2024 | 20.00M | 2.04% |
Apr 17, 2024 | 19.60M | -1.01% |
Apr 16, 2024 | 19.80M | -5.26% |
Apr 15, 2024 | 20.90M | -0.95% |
Apr 12, 2024 | 21.10M | 1.93% |
Apr 11, 2024 | 20.70M | -10.00% |
Apr 10, 2024 | 23.00M | 13.86% |
Apr 9, 2024 | 20.20M | -11.79% |
Apr 8, 2024 | 22.90M | 73.48% |
Apr 5, 2024 | 13.20M | -12.58% |
Apr 4, 2024 | 15.10M | -18.82% |
Apr 3, 2024 | 18.60M | -7.46% |
Apr 2, 2024 | 20.10M | -1.95% |
Apr 1, 2024 | 20.50M | -7.66% |
Mar 28, 2024 | 22.20M | 5.21% |
Mar 27, 2024 | 21.10M | -11.34% |
Mar 26, 2024 | 23.80M | -11.85% |
Mar 25, 2024 | 27.00M | -1.82% |
Mar 22, 2024 | 27.50M | -3.51% |
Mar 21, 2024 | 28.50M | - |
Mar 20, 2024 | 28.50M | 91.28% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
NeuroBo Pharmaceuticals | 15.21M |
Mainz Biomed B.V. | 15.05M |
BioSig Technologies | 14.78M |
Pieris Pharmaceuticals | 14.75M |
Avalo Therapeutics | 14.68M |
Immuron | 14.19M |
BIMI International Medical | 14.02M |
Trinity Biotech | 13.98M |